Eledon Pharmaceuticals, Inc.
Ticker: ELDN
| Insider | Title |
|---|---|
| Allan Kirk | Director |
| Bryan E. Smith | General Counsel, Corporate Sec |
| David-alexandre C Gros | Chief Executive Officer, Director |
| Gary A Lyons | Director |
| Gp Holdings Llc Bvf | 10% or greater ownership |
| I Gp Llc Bvf | See Explanation of Responses |
| Ii Gp Llc Bvf | See Explanation of Responses |
| Inc/il Bvf | 10% or greater ownership |
| James A. Jr. Robinson | Director |
| Jan Hillson | Director |
| John S. Mcbride | Director |
| June Lee | Director |
| Keith Katkin | Director |
| Mark N Lampert | 10% or greater ownership |
| Partners L P/il Bvf | 10% or greater ownership |
| Partners Os Ltd. Bvf | See Explanation of Responses |
| Paul Sean Little | Chief Financial Officer |
| Steven Perrin | President, Director |
| Value Fund Ii Lp Biotechnology | See Explanation of Responses |
| Value Fund L P Biotechnology | See Explanation of Responses |
| Value Trading Fund Os Lp Biotechnology | See Explanation of Responses |
| Walter C Ogier | Director |